BSE filing, NSE: MACINTR. Summary written from the filing by ALFA Finder's alert engine.
Astal Laboratories Ltd: key numbers
- Share price
- ₹59.50
- Market cap
- ₹251.2 Cr
- Revenue (annual)
- ₹156.0 Cr
- Net profit (annual)
- ₹8.12 Cr
- P/E (TTM)
- 25.8×Sector 46.8×
- Promoter holding
- 4.59%+0.06% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Astal Laboratories Ltd
All →Astal Laboratories Other Announcement
Astal Laboratories submitted the Regulation 74(5) certificate from its Registrar for the quarter ended September 30, 2026, confirming the dematerialization activities.
Astal Laboratories Other Announcement
Astal Laboratories' material subsidiary, Sriven Pharmachem India, appointed new Internal, Cost, and Secretarial Auditors. The appointments were approved during the subsidiary's board meeting on September 28, 2026.
Astal Laboratories Management Change
Astal Laboratories Limited has appointed Ms. Ambika Kedia as Company Secretary of its material wholly-owned subsidiary, Sriven Pharmachem India Private Limited. The appointment is effective from September 28, 2026.
Astal Laboratories Annual General Meeting
Astal Laboratories held its 33rd Annual General Meeting on September 29, 2026. Members transacted business regarding financial statements and the re-appointment of a director.
Astal Laboratories Promoter Buying: ₹0.2 Cr
Promoter Aceso Research Labs LLP acquired 25,417 equity shares of Astal Laboratories Ltd via market purchase, increasing their stake from 4.53% to 4.59%.
- Value
- ₹0.20 Cr
- Promoter stake change
- +0.06%
Astal Laboratories Promoter Buying
Astal Laboratories' promoter ACESO Research Labs LLP bought equity shares on BSE under a SEBI PIT disclosure. The open-market purchase signals promoter confidence.
Other board meeting date announcements
All →Phyto Chem (India) Board Meeting Date
Phyto Chem India intimated a board meeting on 14-11-2026 to consider unaudited financial results for Q2 and half year ended 30-09-2026. The trading window stays closed until 48 hours after results are announced.
Crescentis Capital Board Meeting Date
Crescentis Capital Ltd intimated BSE of a board meeting on 12 November 2026 to approve Q2 and half-year unaudited results. It also notes the trading window stays closed until 48 hours after results.
GVP Infotech Board Meeting Date
GVP Infotech will hold a board meeting on 18 November 2026 to consider unaudited half-yearly results. Trading window closes until 20 November 2026.
Viaz Tyres Board Meeting Date
Viaz Tyres will hold a board meeting on 13 November 2026 to consider unaudited half-yearly results. Trading window closes until 15 November 2026.
Cindrella Hotels Board Meeting Date
Cindrella Hotels intimated a board meeting on 14 November 2026 to consider unaudited results for the quarter ended 30 September 2026. This is advance notice; the results are not yet approved.
Moksh Ornaments Board Meeting Date
Moksh Ornaments Limited has intimated a board meeting on 14 November 2026 to consider unaudited standalone quarterly results for September 2026 and other business. Trading window is closed from 1 October to 16 November 2026.